Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles
Antiretroviral therapy (ART) for the treatment of HIV-1 requires life-long daily adherence to supress viral replication, and nucleoside reverse transcriptase inhibitors that are commonly used in ART have not been converted into long-acting agents. Here, the authors report two lipophilic tenofovir (T...
Guardado en:
Autores principales: | Denise A. Cobb, Nathan Smith, Suyash Deodhar, Aditya N. Bade, Nagsen Gautam, Bhagya Laxmi Dyavar Shetty, JoEllyn McMillan, Yazen Alnouti, Samuel M. Cohen, Howard E. Gendelman, Benson Edagwa |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e78ef827a6654617b246aed85af2acee |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir
por: Nagsen Gautam, et al.
Publicado: (2021) -
Creation of a long-acting nanoformulated dolutegravir
por: Brady Sillman, et al.
Publicado: (2018) -
Synthesis and characterization of a long-acting emtricitabine prodrug nanoformulation
por: Ibrahim IM, et al.
Publicado: (2019) -
Tenofovir induced lichenoid drug eruption
por: Mrinal Gupta, et al.
Publicado: (2015) -
Weak tides during Cryogenian glaciations
por: J. A. Mattias Green, et al.
Publicado: (2020)